2.715

2.45% 0.065

After Hours: 2.71 -0.005 -0.18%

Aytu Biopharma Inc (AYTU)

Overview News Price History Financials Why AYTU Down? Discussions Forecast Stock Split

Aytu Biopharma Inc stock is traded at $2.715, with a volume of 44,285. It is up +2.45% in the last 24 hours and up +17.53% over the past month. Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Previous Close:

$2.65

Open:

$2.67

24h Volume:

44,285

Relative Volume:

0.54

Market Cap:

$29.14M

Revenue:

$62.64M

Net Income/Loss:

$-24.56M

P/E Ratio:

-0.7073

EPS:

-3.8387

Net Cash Flow:

$-3.70M

1W Performance:

+4.42%

1M Performance:

+17.53%

6M Performance:

+45.97%

1Y Performance:

+113.78%

1-Day Range:

$2.6548

$2.72

1-Week Range:

$2.55

$2.72

52-Week Range:

$0.95

$3.065

Aytu Biopharma Inc Stock (AYTU) Company Profile

Name

Aytu Biopharma Inc

Sector

Healthcare (1114)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

(720) 437-6580

Address

7900 E. UNION AVENUE, DENVER

Employee

Twitter

@aytubioscience

Next Earnings Date

2024-12-13

Latest SEC Filings

AYTU's Discussions on Twitter

Compare AYTU vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AYTU Aytu Biopharma Inc	2.715	28.44M	62.64M	-24.56M	-3.70M	-3.8387
TAK Takeda Pharmaceutical Co Adr	18.29	56.99B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	116.71	48.94B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.74	43.30B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	29.46	33.94B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	541.60	23.31B	3.18B	1.33B	1.04B	27.90

Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-01-25	Initiated	Lake Street	Buy
Jun-30-25	Initiated	Ascendiant Capital Markets	Buy
Mar-30-21	Initiated	Cantor Fitzgerald	Overweight
May-29-20	Initiated	H.C. Wainwright	Buy

Aytu Biopharma Inc Stock (AYTU) Latest News

Mar 25, 2026

Aug Big Picture: Will Aytu BioPharma Inc benefit from rising consumer demandDip Buying & Stepwise Trade Signal Guides - baoquankhu1.vn

Mar 25, 2026

Mar 22, 2026

If You Invested $1,000 in Aytu Biopharma Inc (AYTU) - Stock Titan

Mar 22, 2026

Mar 17, 2026

History Review: What hedge funds are buying Aytu BioPharma Inc2026 Price Momentum & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Mar 17, 2026

Aytu BioPharma : Corporate Presentation March 2026 View Presentation Investor Day January 2026 View Presentation - marketscreener.com

Mar 17, 2026

Mar 11, 2026

Bull Run: Will Aytu BioPharma Inc benefit from rising consumer demand2026 Retail Activity & AI Based Trade Execution Alerts - baoquankhu1.vn

Mar 11, 2026

Mar 07, 2026